Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.75 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.75 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26184961 | 0.95 | GPR84 (0.82) | GPR84FFAR1CA2MAPK1CHRM1 | |
| SCHEMBL28555 | 0.95 | — | — | |
| SCHEMBL360108 | 0.95 | — | — | |
| SCHEMBL4378353 | 0.95 | — | — | |
| Hydrogen Peroxide SCHEMBL27840097 | 0.95 | GPR84 (0.82) | GPR84FFAR1CA2MAPK1CHRM1 | |
| SCHEMBL3783329 | 0.94 | GPR84 (0.67) | GPR84FFAR1CA2MAPK1CHRM1 | |
| SCHEMBL28425913 | 0.93 | GPR84 (0.78) | GPR84FFAR1CA2MAPK1CHRM1 | |
| Ethane SCHEMBL5400213 | 0.93 | GPR84 (0.78) | GPR84FFAR1CA2MAPK1CHRM1 | |
| SCHEMBL28800209 | 0.93 | GPR84 (0.78) | GPR84FFAR1CA2MAPK1CHRM1 | |
| SCHEMBL28848609 | 0.93 | GPR84 (0.78) | GPR84FFAR1CA2MAPK1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6664287-B2 | Antioxidants | BETHESDA PHARMACEUTICALS, INC. | 2003-12-16 | — | — | US | disclosed |
| WO-2003084532-A1 | LIPOIC ACID ANALOGS USEFUL AS PROVITAMINS AND ANTIOXIDANTS | AVERY MITCHELL A (US) | 2003-10-16 | — | — | WO | disclosed |
| EP-1207846-A1 | TOWELETTE PRODUCT | UNILEVER PLC (GB) | 2002-05-29 | — | — | EP | disclosed |
| US-20020048798-A1 | Novel antioxidants | AVERY MITCHELL ALLEN (US) | 2002-04-25 | — | — | US | disclosed |
| WO-2001013880-A1 | TOWELETTE PRODUCT | UNILEVER PLC (GB) | 2001-03-01 | — | — | WO | disclosed |
| US-5607980-A | AMPHOTERIC, ANIONIC, CATIONIC SURFACTANTS AND WATER | THE PROCTER & GAMBLE COMPANY (US) | 1997-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020048798-A1 | Novel antioxidants | CUTA, LIPG, NFATC1 | GPR84 2650/4885FFAR1 185/4885CA2 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.